CDK4 and breast carcinoma: In two established CDK4/6i resistant breast cancer cell lines (MCF7-PalR and MCF7-AbeR) (Fig. S1, A and B), we observed downregulation of NSRP1 protein expression compared with the parental MCF7 cells (Fig. 1F).